These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Morphology and DNA content of endometrial cancer nuclei under progestogen treatment. Hustin J Acta Cytol; 1976; 20(6):556-8. PubMed ID: 1069452 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastasizing carcinoma of the uterus with gestagens]. Engeler V Schweiz Med Wochenschr; 1971 Dec; 101(52):1906-9. PubMed ID: 5141283 [No Abstract] [Full Text] [Related]
7. [Effective progestogen therapy of endometrial hyperplasia and adenocarcinoma by administration of a combined progestogen-estrogen preparation]. Miyawaki Y; Ueki M; Sugimoto O Nihon Gan Chiryo Gakkai Shi; 1988 Oct; 23(10):2598-605. PubMed ID: 3209928 [No Abstract] [Full Text] [Related]
8. [Endometrial carcinoma and their precursors]. Philippe E; Muller J; Ritter J Rev Fr Gynecol Obstet; 1987 May; 82(5):331-5. PubMed ID: 3602808 [TBL] [Abstract][Full Text] [Related]
10. Cytochemical detection of nickel in endometrial carcinoma during progestogen treatment. Patai K; Szarvas Z; Balogh I Acta Chir Hung; 1989; 30(3):199-204. PubMed ID: 2596239 [TBL] [Abstract][Full Text] [Related]
11. [Uterus septus with adenocarcinoma of one half of the uterus]. Beyer WF; Freissler G; Schlotter CM; Kühn H Geburtshilfe Frauenheilkd; 1984 Aug; 44(8):513-5. PubMed ID: 6566640 [TBL] [Abstract][Full Text] [Related]
12. [Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer]. Thurzó L Zentralbl Gynakol; 1990; 112(17):1111-5. PubMed ID: 2148245 [TBL] [Abstract][Full Text] [Related]
13. The effects of the selective progesterone receptor modulator asoprisnil on the morphology of uterine tissues after 3 months treatment in patients with symptomatic uterine leiomyomata. Williams AR; Critchley HO; Osei J; Ingamells S; Cameron IT; Han C; Chwalisz K Hum Reprod; 2007 Jun; 22(6):1696-704. PubMed ID: 17339234 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and histological studies of endometrial carcinoma of the uterus treated with medroxy-progesterone-acetate (author's transl)]. Ohta M; Takeda A; Ninagawa T; Tomoda Y Nihon Gan Chiryo Gakkai Shi; 1980 Dec; 15(7):1098-103. PubMed ID: 6453176 [No Abstract] [Full Text] [Related]
15. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study. Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836 [No Abstract] [Full Text] [Related]
16. Short-term progestogen treatment of endometrial carcinoma. Histological, histochemical and hormonal studies. Moe N Acta Obstet Gynecol Scand; 1972; 51(1):55-62. PubMed ID: 4261828 [No Abstract] [Full Text] [Related]
17. [Aspects of the endometrium in women with adenocarcinoma of the body of the uterus in advanced menopause]. Bianchi F; Evoli M; Talamazzi F Minerva Ginecol; 1968 Sep; 20(18):1500-2. PubMed ID: 5740775 [No Abstract] [Full Text] [Related]
18. [Correlation of cervicovaginal cytology and histology in endometrial cancer]. Nagy P; Keller G Zentralbl Gynakol; 1989; 111(18):1241-5. PubMed ID: 2588855 [TBL] [Abstract][Full Text] [Related]
19. Shadow cell differentiation in tumours of the colon and uterus. Zámecník M; Michal M Zentralbl Pathol; 1995 Apr; 140(6):421-6. PubMed ID: 7538784 [TBL] [Abstract][Full Text] [Related]
20. [Study of 505 cases of abnormal uterine hemorrhage and anatomo-clinical correlation with the endometrial biopsy]. Bravo Sandoval J; López Ortiz E; López Villegas J; Chávez Fraga E; Góngora P; Uribe R Ginecol Obstet Mex; 1969 Sep; 26(155):355-66. PubMed ID: 5402853 [No Abstract] [Full Text] [Related] [Next] [New Search]